Genome Guided Personalized Drug Therapy in Attention Deficit Hyperactivity Disorder
ADHD is a common behavioral syndrome with a heritability of 70–80%. Genome wide sequencing and association studies indicate that ADHD risk variants are distributed across a wide range of allele frequencies and relative risks. Several common single nucleotide variants (SNPs) have been identified that...
Main Author: | Jan Haavik |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-06-01
|
Series: | Frontiers in Psychiatry |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fpsyt.2022.925442/full |
Similar Items
-
Case report: ADHD and prognosis in tyrosinemia type 1
by: Helene Barone, et al.
Published: (2023-07-01) -
Risk factors of suicidal spectrum behaviors in adults and adolescents with attention-deficit / hyperactivity disorder – a systematic review
by: Amalie Austgulen, et al.
Published: (2023-08-01) -
Candidate Gene Studies of Attention Deficit Hyperactivity Disorder
by: Esra Guney, et al.
Published: (2011-12-01) -
Epilepsy and Attention Deficit Hyperactivity Disorder: Connection, Chance, and Challenges
by: Hueng-Chuen Fan, et al.
Published: (2023-03-01) -
Gene-Environment Interactions in Attention-Deficit/Hyperactivity Disorder Symptom Dimensions: The Role of Unhealthy Food Habits
by: Lin Li, et al.
Published: (2021-12-01)